An integrated multi-omics study of key mediators and therapeutic targets for doxorubicin-induced atrial fibrillation
Zhenli Li, Sihan Liu, Jing He, Tenghui Wang, Jingtao Ma · 2026
Read An integrated multi-omics study of key mediators and therapeutic targets for doxorubicin-induced atrial fibrillation by Zhenli Li, Sihan Liu, Jing He, Tenghui Wang, Jingtao Ma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353143.txt.
Description
Li and colleagues combined several data layers to find drivers of irregular heartbeat caused by a cancer drug in a 2026 study. The drug, widely used against cancer, can trigger atrial fibrillation, a serious rhythm problem. The team started with drug safety reports, then layered gene, protein network, and immune data.
Candidate targets emerged where drug targets, disease genes, and changed genes overlapped. Hub genes were checked in independent data sets, and docking tests probed direct binding. Naming the mediators could lead to heart-protecting companions for the cancer drug, so patients gain the cancer benefit with less rhythm risk.
Catalog record
| CREATOR | Zhenli Li, Sihan Liu, Jing He, Tenghui Wang, Jingtao Ma |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39512 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |